PT-141 1.5mg/Oxytocin

PT-141 1.5mg/Oxytocin 500 IU Gummy

A combination gummy formulated to support the body's natural way for intimacy, emotional closeness, and desire, while enhancing the sexual experience.

Compounded medications are not reviewed or approved by the U.S. Food and Drug Administration (FDA). The FDA does not verify the safety, effectiveness, or quality of compounded drugs.

Physician-Guided Continuity of Care

1 Gummy Supply$199

Delivered monthly. Each refill or treatment continuation is thoughtfully reviewed during a follow-up consultation to ensure optimal results and patient safety.

PT-141 is designed to support healthy sexual desire and arousal, and oxytocin provides support to promote intimacy and emotional connection.

PT-141 helps by activating the melanocortin receptors in the central nervous system that are responsible for sexual desire and arousal. Oxytocin helps to activate the receptor of the brain's emotional center to support feelings of closeness, emotional safety, and connection. Together, this gummy is designed to enhance sexual wellness and support desire from both the mind and body.

PT-141 and Oxytocin gummies may help to support improvement in sexual relationship satisfaction and wellness. It may enhance emotional closeness and intimacy in a relationship.

These combination gummies may be suitable for individuals who experience low sexual desire and decreased libido or who want to enhance intimacy and emotional connection. It may also be suitable for individuals who are seeking a non-injectable approach to sexual wellness.

PT-141 and Oxytocin gummies are administered through oral intake. It is indicated to chew and swallow one gummy prior to sexual activity. At AHBARx, our provider will provide guidance on correct medication administration, dosage timing and frequency, and safe medication handling.

Reconnect, Rediscover and Rebuild Intimacy

Supports desire, performance, and connection
Promotes confidence in intimate experiences
Encourages a stronger sense of closeness and bonding
Supports responsiveness and overall sexual wellness
Designed to enhance intimacy from both a physical and emotional perspective

Reference

Edinoff, A. N., Sanders, N. M., Lewis, K. B., Apgar, T. L., Cornett, E. M., Kaye, A. M., & Kaye, A. D. (2022). Bremelanotide for Treatment of Female Hypoactive Sexual Desire. Neurology international, 14(1), 75–88.

Disclaimer

This medication should only be used under the supervision of a qualified healthcare provider. Individual response and suitability may vary. This product is not intended to diagnose, treat, cure, or prevent any disease without proper medical evaluation.

PT-141 1.5mg/Oxytocin